Elicio Therapeutics, Inc. Common Stock (NASDAQ: ELTX) last traded at $1.89, up 4.42% on the session. The quote above updates while this page is open; the figures below are drawn from Elicio Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Elicio Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ELTX. Its market capitalisation is $49.67 million.
Valuation measures for Elicio Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $49.67M |
|---|---|
| Enterprise value | $49.59M |
| Price / book | 6.26 |
| Beta | 0.31 |
Trailing-twelve-month figures tagged in Elicio Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$37.84M |
| Return on equity | -476.77% |
|---|
| Cash | $23.48M |
|---|
Range and volume for ELTX over the past 52 weeks.
| 52-week high | $16.00 |
|---|---|
| 52-week low | $1.71 |
| Volume | 306.2K |
| Average volume | 340.2K |
| Previous close | $1.81 |
Invest a chosen dollar amount in Elicio Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ELTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.